Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.15 USD | -2.28% | -10.87% | -25.12% |
Mar. 13 | UBS Adjusts ALX Oncology Price Target to $25 From $27, Maintains Buy Rating | MT |
Mar. 11 | H.C. Wainwright Adjusts Price Target on ALX Oncology to $20 From $17.50, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 559M |
---|---|---|---|---|---|
Net income 2024 * | -173M | Net income 2025 * | -171M | EV / Sales 2024 * | - |
Net Debt 2024 * | 952K | Net Debt 2025 * | 13.89M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.41
x | P/E ratio 2025 * |
-3.95
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.9% |
Latest transcript on ALX Oncology Holdings Inc.
1 day | -2.28% | ||
1 week | -10.87% | ||
Current month | -23.99% | ||
1 month | -23.16% | ||
3 months | -27.05% | ||
6 months | +125.25% | ||
Current year | -25.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jaume Pons
FOU | Founder | 58 | 15-03-31 |
Jason Lettmann
CEO | Chief Executive Officer | 46 | 20-03-31 |
Peter García
DFI | Director of Finance/CFO | 62 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 22-11-27 |
Corey Goodman
CHM | Chairman | 72 | 15-02-28 |
Jack Nielsen
BRD | Director/Board Member | 60 | 20-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 8 M€ | +9.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11.15 | -2.28% | 1,184,876 |
24-03-27 | 11.41 | +1.97% | 197,181 |
24-03-26 | 11.19 | -4.52% | 261,983 |
24-03-25 | 11.72 | -0.17% | 268,811 |
24-03-22 | 11.74 | -6.16% | 525,141 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.12% | 559M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |